Live Quote · OTCVOQPHealthcare· Biotechnology

VioQuest Pharmaceuticals, Inc.

$0.00 0.00%(+$0.00)
TickerSpark Score
31/100
Poor
20
Valuation
40
Profitability
15
Growth
52
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VOQP research report →

52-Week Range100% of range
Low
$0.00
Current
$0.00
High
$0.00
Company Overviewwww.vioquestpharm.com

About the company

VioQuest Pharmaceuticals, Inc. is a biopharmaceutical entity that concentrates on obtaining, developing, and marketing drug therapies in clinical stages, specifically targeting oncology and infectious diseases. Its primary product, Xyfid, is currently being advanced for both the management and prevention of hand-foot syndrome.

CEO
Mark D. Dacko
IPO
1994
Employees
3
HQ
Basking Ridge, NJ, US

Price Chart

+0.00% · this period
$0.00$0.00$0.00Jul 02Dec 31Jul 02
Valuation
Market Cap
$14.72K
P/E
-0.00
P/S
0.00
P/B
-0.00
EV/EBITDA
-0.34
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
1325.43%
ROIC
-613.09%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-10,891,741 · -31.68%
EPS
$-2.33 · -12.02%
Op Income
$9.74M
FCF YoY
-9.27%
Performance & Tape
52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-0.33
Avg Volume
63.2

Get TickerSpark's AI analysis on VOQP

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jul 21, 08SCHNITTKER CHRISTOPHER Pother180,000
Jul 21, 08SCHNITTKER CHRISTOPHER Pother0
Jun 13, 08WEISER MICHAELother100,000
Jun 13, 08WEISER MICHAELother10,000
Jun 13, 08WEISER MICHAELother1,290
Jun 13, 08WEISER MICHAELsell10,000
Jun 13, 08WEISER MICHAELsell1,290
Mar 14, 08WEISER MICHAELother10.57
Mar 14, 08WEISER MICHAELother2,631
Coverage · VOQP

Our VOQP coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on VOQP yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate VOQP report →
Internal Compare

Similar companies

Peers in the same neighborhood.